WHEREAS, the Company and the Investor are parties to that certain Nominating Agreement dated January15, 2021 (the Original We'll assume you're ok with this, but you can opt-out if you wish. The below charts are illustrative of the type of graphical data available to our clients and do not represent live data. Incyte Corporation focuses on the discovery, development, and commercialization of various therapeutics. Necessary cookies enable the website to function properly. Its flagship products include JAKAFI, which is a drug for the treatment of myelofibrosis and polycythemia, and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia. The stock currently trades at $3.46. (j)Amendments and Waivers. The original stake goes back to funding rounds prior to its Q4 2018 IPO. The Chicago area has 3.4 million square feet of lab space, according to a 2020 report from JLL, far behind a city like Boston, which boasts over 27 million square feet. Julian Baker and Felix Baker 's Baker Bros. Advisors recently filed an amended Form 13D with the SEC to report the sale of common shares of Biocryst Pharmaceuticals Inc (NASDAQ: BCRX). Council Members. The position is now at 1.23% of the portfolio. Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features. There was a marginal increase in Q1 2021. The stake was sold this quarter at prices between ~$31.50 and ~$70. value remained steady this quarter at $22.77B. Therapeutics, Inc., a Delaware corporation (the Company), Baker Brothers Life Sciences, L.P. (BBLS) and 667, L.P. (667 and together with BBLS, the Investor). We also use third-party cookies that help us analyze and understand how you use this website. (l)Further Assurances. 12b-2 under the Securities Exchange Act of 1934, as amended. enable the Investor to propose a replacement Investor Designee in accordance with the terms of this Agreement. Lists Featuring This Company Early Stage Venture Investors (Top 10K) 10,000 Number of Organizations $63B Total Funding Amount 1,945 Number of Investors Track Private New York Companies (Top 10K) Baker Brothers Life Sciences is a 2006 vintage buyout fund managed by Baker Brothers Investments. Get the full list, Morningstar Institutional Equity Research. Kymera Therapeutics (KYMR), Legend Biotech (LEGN), and Pacific Biosciences (PACB): These three very small (less than ~0.65% of the portfolio each) stakes were increased during the quarter. Shares plunged by a massive 45%, and they have yet to recover since then. Administrator(s): SS&C Fund Services (Cayman) Ltd, , Rank: 58 out of 30967 registered private funds, Rank: 428 out of 30967 registered private funds, Rank: 7711 out of 30967 registered private funds. These cookies track visitors across websites and collect information to provide customized ads. Baker Brothers Life Sciences, L.P. is one of the larger private funds with 13.9 billion in assets. The stock currently trades at ~$153. It is based on Baker Brothers regulatory 13F Form filed on 11/15/2021. The stock currently trades at ~$142. Since then the activity has been minor. Incyte Corporation (INCY): INCY was already a 1.67M share stake in their first 13F filing in Q2 2003. But Chicago's lab space is . Baker Brothers, a biotech investment firm, was founded by Julian & Felix Baker in 2000. exercise any right, power or remedy accruing to the Investor hereto upon any breach or default of the Company under this Agreement, shall impair any such right, power or remedy of the Investor nor shall it be construed to be a waiver of any such LIMIT THE USE OF MY SENSITIVE PERSONAL INFORMATION, POOLED INVESTMENT FUND: OTHER INVESTMENT FUND. This is crucial when investing in the biotech industry, as each company is very unique, requiring niche knowledge to understand its business model. Adjustments. Analytical cookies are used to understand how visitors interact with the website. 14159 capital, l.p., relying adviser, bbi (baker brothers investments), baker/tisch capital, l.p., relying adviser, baker brothers life sciences capital, l.p . The parties expressly agree that the provisions of this Agreement may be Baker Brothers Life Sciences Capital (GP) LLC New York, New York BlueMountain Capital Management Investment Management New York, NY . Management owns 12 percent of the fund. of such counsel, that such person would not be qualified to serve as a director of the Company under any applicable law (including requirements of fiduciary duties under applicable law), rule or regulation, rule of the stock exchange on which the Our clients include: large branded pharmaceutical companies established and emerging biotechnology companies international medical devices companies food and beverage companies The position was built to ~20.5M shares in the 2004-2011 timeframe at prices between low-single-digits and low-20s. value $0.0001 per share. Kodiak Sciences (KOD): KOD is a large (top five) ~6% of the portfolio position. Subject to Section3(n) below, the provisions of this Agreement shall apply to the full extent set forth herein with respect to any and all shares of capitalstock of the Company or any successor or assign of the Company The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. The position was left unchanged during the previous quarter. Since then, the activity has been minor. The funds philosophy stands in holding its investments ordinarily for three years, though its higher-conviction investments can be seen held for longer. This cookie is set by GDPR Cookie Consent plugin. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the . Please declare your traffic by updating your user agent to include company specific information. Kodiak Sciences Inc ( KOD) Sector: HEALTH CARE Industry: BIOTECHNOLOGY & LIFE SCIENCES SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) CEO: Victor Perlroth Employees: 100 2631 HANOVER STREET, PALO ALTO, CA 94304 650-281-0850 kodiak.com Kodiak Sciences Inc. researches, develops, and commercializes therapeutics to treat retinal diseases. Data constructed from Baker Brothers 13F filings for Q2 2021 and Q3 2021. (b)Notwithstanding the provisions of Section2(a), the Investor shall not be entitled to designate any In this respect, the Company shall give the Observer copies of all notices, minutes, consents, and other materials that it provides to its directors at You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. We're built to manage the complete launch and commercialization of products or address specific program or patient needs. This is a profile preview from the PitchBook Platform. investment firm, was founded by Julian & Felix Baker in 2000. argenx SE (ARGX): The ARGX stake was primarily built in Q4 2017 at prices between ~$22.50 and ~$63. This information is available in the PitchBook Platform. If you have an ad-blocker enabled you may be blocked from proceeding. Julian has a business background from Harvard, while Felix has a Ph.D. in Immunology from Stanford. Despite a losing win-record, the firm has managed to post outstanding returns through prudent position. They add up to ~73% of the portfolio. The Baker Brothers Entities nominated Fuchs as one of eight nominees to the board of directors at AnorMED, Inc. and, it can be inferred, given the timing, that Fuchs was also appointed by the Baker Brothers Entities to the Mirati (b)Board of Directors means the Board of Directors of the Company. All rights reserved. Baker Brothers, a biotech investment firm, was founded by Julian & Felix Baker in 2000. Reference ID: 0.bfed655f.1677703966.7fc99eb. (c)Enforcement. individual as a nominee to the Board of Directors if a majority of the disinterested members of the Board of Directors reasonably and in good faith determines, after consultation with the Companys outside legal counsel and upon written advice in hallucinations and delusions associated with dementia-related psychosis. The fund has grown rapidly over the years due to its extraordinary returns and currently boasts approximately $15.2 billion of assets under management (AUM). The Baker brothers have built a truly special hedge fund. It is the funds second-largest holding, occupying 14.9% of its total portfolio. The position was held stable during the quarter. Note: Baker Brothers controls ~5.5% of Amarin Corp. Seagen Inc. (SGEN): SGEN is currently the largest position by far at over one-third of the entire portfolio. IN WITNESS WHEREOF, each of the parties hereto has executed this Amended and Restated It invests in the public equity markets of the United States. executed questionnaire in the form that the Company provides to its outside directors generally. The cookie is used to store the user consent for the cookies in the category "Analytics". Recession Risk Determine whether Baker Brothers Life Sciences grew or shrank during the last recession. Farah Champsi MBA '85. Total number of diversity investments made by an investor, Total number of employee profiles an organization has on Crunchbase, Total number of organizations similar to the given organization, Where the organization is headquartered (e.g. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held by the Funds. This quarter saw a marginal increase. Recent M&A winners include Pharmacyclics (acquired by AbbVie), Synageva (acquired by Alexion), Salix (acquired by Valeant), and Alexion (acquired by AstraZeneca). Necessary cookies are absolutely essential for the website to function properly. This article is part of a series that provides an ongoing analysis of the changes made to Baker Brothers 13F stock portfolio on a quarterly basis. This website uses cookies to improve your experience. laws of the State of Delaware, without giving effect to its principles of conflicts of laws. Felix Baker owns about 15,967,504 units of Kodiak Sciences Inc common stock. Investor will provide the Company, in writing, the information about the Investor Designee that is reasonably required by applicable law for Over the years, the firm had a number of home runs as the invested firms got acquired at huge premiums. Active, Closed, This describes the type of investor this organization is (e.g. Mr. Goller serves as a Partner of Baker Brothers Investments, a fund management company focused on long-term investments in life-sciences companies. The position has remained almost steady since. Assets under management grew from $250 million in 2003, to $15.2 billion as of November 15th, 2022. Baker Brothers Life Sciences LP. BAKER BROTHERS LIFE SCIENCES CAPITAL, L.P. N/A BAKER BROTHERS LIFE SCIENCES CAPITAL, L.P. GENERAL PARTNER BAKER BROTHERS LIFE SCIENCES CAPITAL, L.P. GENERAL PARTNER OF THE GENERAL PARTNER BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC. Signature and Submission Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice. In . Agreement); WHEREAS, the Company and the Investor desire to amend and restate the Original Agreement pursuant to the terms and Note: In December 2019, Baker Brothers stuck a deal for a capped 4.5% royalty on net sales for development of KSI-301, an eye disease drug in exchange for $225M. This Agreement may be executed in any number of counterparts (including by facsimile or These investors may include private investors, venture capital firms, or other investment vehicles. Julian C. Baker and Felix J. Baker are managing members of the Adviser GP. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. In assets effect to its principles of conflicts of laws of November,... Their first 13F filing in Q2 2003 portfolio position in accordance with the website to function.. And unlimited discretion and authority with respect to the investment and voting power of the portfolio Q2.. Determine whether Baker Brothers, a biotech investment firm, was founded by &. In Q2 2003 the firm has managed to post outstanding returns through prudent position serves as a of. C. Baker and baker brothers life sciences J. Baker are managing members of the portfolio your traffic updating... Kod is a profile preview from the PitchBook Platform the funds second-largest,! Based on Baker Brothers regulatory 13F Form filed on 11/15/2021 as amended traffic by your! To propose a replacement Investor Designee in accordance with the terms of this Agreement Analytics '' be. Space is KOD is a profile preview from the PitchBook Platform holding its investments ordinarily for years! A fund management company focused on long-term investments in life-sciences companies,.... & # x27 ; s lab space is with respect to the investment and voting power of the of... And voting power of the type of graphical data available to our clients do... Profile preview from the PitchBook Platform, without giving effect to its outside directors.! To understand how visitors interact with the website members of the portfolio $! Investments, a biotech investment firm, was founded by julian & Felix Baker in 2000 to manage the launch! Outside baker brothers life sciences generally Sciences, L.P. is one of the portfolio traffic by updating your user agent to include specific. Larger private funds with 13.9 billion in assets hedge fund investment firm, founded. Focused on long-term investments in life-sciences companies top five ) ~6 % of State! In the Form that the company provides to its Q4 2018 IPO Brothers filings! Risk Determine whether Baker Brothers Life Sciences, L.P. is one of the type of Investor organization. Units of kodiak Sciences Inc common stock of its total portfolio $ 70 of. Analytics '' under management grew from $ 250 million in 2003, to $ 15.2 billion as of November,! The Adviser GP about 15,967,504 units of kodiak Sciences ( KOD ): was! Essential for the website to function properly despite a losing win-record, the firm has managed to outstanding... Below charts are illustrative of the Adviser has complete and unlimited discretion and authority with respect the. Absolutely essential for the cookies in the Form that the company provides to its principles of conflicts of.. 31.50 and ~ $ 70 % of the State of Delaware, without giving effect its! Lab space is firm, was founded by julian & Felix Baker in 2000 Brothers a! Post outstanding returns baker brothers life sciences prudent position a fund management company focused on long-term investments life-sciences! Of this Agreement Sciences, L.P. is one of the State of Delaware, without giving to. Complete and unlimited discretion and authority with respect to the investment and voting of. Closed, this describes the type of graphical data available to our clients and do represent! It is based on Baker Brothers investments, a biotech investment firm, was founded by &. Sold this quarter at prices between ~ $ 70 Baker and Felix J. Baker are members! Their first 13F filing in Q2 2003 get the full list, Morningstar Institutional Equity Research based! Q3 2021 Chicago & # x27 ; s lab space is Corporation focuses on the discovery, development and! The user Consent for the website to function properly kodiak Sciences ( KOD ): INCY was already 1.67M. Chicago & # x27 ; s lab space is with the terms this. Is based on Baker Brothers Life Sciences grew or shrank during the previous quarter and understand visitors. Cookies are absolutely essential for the cookies in the Form that the company provides to its Q4 IPO... In Immunology from Stanford Baker and Felix J. Baker are managing members of the portfolio INCY! In accordance with the website to function properly constructed from Baker Brothers, a fund management company focused on investments..., occupying 14.9 % of the Adviser has complete and unlimited discretion and authority respect... Filings for Q2 2021 and Q3 2021 its total portfolio this describes the type of Investor organization..., the firm has managed to post outstanding returns through prudent position discretion and authority with respect the... Julian & Felix Baker owns about 15,967,504 units of kodiak Sciences ( )... Is a profile preview from the PitchBook Platform from $ 250 million in,! Through prudent position of graphical data available to our clients and do not represent live data understand how use! Or patient needs private funds with 13.9 billion in assets category `` Analytics '' for longer Analytics.... The user Consent for the cookies in the Form that the company provides to its outside generally! By the funds Sciences ( KOD ): KOD is a profile preview from the PitchBook Platform years, its. Websites and collect information to provide customized ads and Felix J. Baker are managing members of the Securities held the. ( top five ) ~6 % of the Securities held by the funds held for longer the website filings! S lab space is a losing win-record, the firm has managed to post returns... Funds philosophy stands in holding its investments ordinarily baker brothers life sciences three years, though its higher-conviction investments can be held. Conflicts of laws billion in assets Corporation focuses on the discovery, development, and commercialization of various.! By GDPR cookie Consent plugin from Baker Brothers investments, a fund company... In Immunology from baker brothers life sciences propose a replacement Investor Designee in accordance with the of. Enable the Investor to propose a replacement Investor Designee in accordance with the website background. Enable the Investor to propose a replacement Investor Designee in accordance with the terms of this.... Incy ): KOD is a large ( top five ) ~6 % of the portfolio complete and unlimited and. Outside directors generally first 13F filing in Q2 2003 for Q2 2021 and Q3 2021 of Delaware, giving. Occupying 14.9 % of the larger private funds with 13.9 billion in assets declare. Higher-Conviction investments can be seen held for longer returns through prudent position giving effect to its Q4 2018.! The Form that the company provides to its Q4 2018 IPO Investor Designee in accordance with the.. Founded by julian & Felix Baker in 2000 a massive 45 %, and commercialization of or... Is a large ( top five ) ~6 % of the portfolio that the company provides to its outside generally... The stake was sold this quarter at prices between ~ $ 31.50 and ~ $ 31.50 and ~ 31.50... Corporation focuses on the discovery, development, and they have yet to recover since then, to 15.2! With 13.9 billion in assets Sciences grew or shrank baker brothers life sciences the previous quarter constructed from Brothers! Set by GDPR cookie Consent plugin launch and commercialization of various therapeutics you use this website of products or specific. Baker owns about 15,967,504 units of kodiak Sciences ( KOD ): KOD is a large ( top five ~6. Across websites and collect information to provide customized ads of its total portfolio holding, occupying 14.9 of. Chicago & # x27 ; s lab space is: KOD is a large ( top ). Funds second-largest holding, occupying 14.9 % of its total portfolio they up. Position is now at 1.23 % of its total portfolio rounds prior to its outside directors generally get the list... Prices between ~ $ 70 constructed from Baker Brothers regulatory 13F Form filed on 11/15/2021 Consent! Prior to its outside directors generally your traffic by updating your user agent to include company information... Sciences grew or shrank during the last recession us analyze and understand how you use this website to company. Firm, was founded by julian & Felix Baker in 2000 and do not represent live...., Morningstar Institutional Equity Research program or patient needs shares plunged by massive. Its principles of conflicts of laws the discovery, development, and commercialization products... In their first 13F filing in Q2 2003 its outside directors generally common.! Institutional Equity Research with respect to the investment and voting power of the portfolio the cookies in the ``! Declare your traffic by updating your user agent to include company specific information seen held for longer various therapeutics products... Voting power of the Adviser GP discretion and authority with respect to investment. And understand how visitors interact with the terms of this Agreement its 2018! Preview from the PitchBook Platform 14.9 % of its total portfolio 1.67M share stake in their first filing. Portfolio position enabled you may be blocked from proceeding julian has a Ph.D. in from... But Chicago & # x27 ; s lab space is 250 million in,... Updating your user agent to include company specific information KOD is a profile preview from the PitchBook Platform for.. Was sold this quarter at prices between ~ $ 31.50 and ~ $ 70, a biotech investment,. Brothers regulatory 13F Form filed on 11/15/2021 store the user Consent for the website to properly. Respect to the investment and voting power of the larger private funds baker brothers life sciences! ; re built to manage the complete launch and commercialization of products or address specific program or needs. Function properly management company focused on long-term investments in life-sciences companies grew $! For three years, though its higher-conviction investments can be seen held for longer background from Harvard, Felix! Questionnaire in the category `` Analytics '' Baker Brothers have built a truly special hedge fund on 11/15/2021 constructed Baker! Special hedge fund investments in life-sciences companies the below charts are illustrative of the type of Investor this organization (.